An update on the treatment of CNS metastases in small cell lung cancer

Cancer Journal

Volumn 14, Issue 3, 2008, Pages 138-146

  Castrucci, William A ^a   Knisely, Jonathan P S ^a,b  

^a YALE CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain metastases; Prophylactic cranial irradiation; Small cell lung carcinoma; Whole brain radiation

Indexed keywords

CARBOPLATIN; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; TEMOZOLOMIDE; TENIPOSIDE; TOPOTECAN;

BLOOD TOXICITY; BRACHYTHERAPY; BRAIN METASTASIS; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PREVENTION; CANCER SURGERY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CHEMOTHERAPY INDUCED EMESIS; CLINICAL PRACTICE; CLINICAL TRIAL; HUMAN; LUNG SMALL CELL CANCER; MONOTHERAPY; NAUSEA; NEUROLOGIC DISEASE; NEUROTOXICITY; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RADIATION INJURY; REVIEW; SKULL IRRADIATION; TREATMENT RESPONSE; BRAIN; BRAIN TUMOR; DRUG EFFECT; LUNG TUMOR; METASTASIS; PATHOLOGY; RADIATION EXPOSURE; SMALL CELL CARCINOMA; TOXICITY AND INTOXICATION;

BRAIN; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; CRANIAL IRRADIATION; HUMANS; LUNG NEOPLASMS; NEUROTOXICITY SYNDROMES;

EID: 52649152592     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e318172d6e1     Document Type: Review

References (66)

1. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006;24:4539-4544.
2. Simon GR, Turrisi A. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd ed.). Chest. 2007;132: 324S-339S.
3. Jackman DM, Johnson BE. Small-cell lung cancer. Lancet. 2005;366: 1385-1396.
4. El Maalouf G, Rodier JM, Faivre S, et al. Could we expect to improve survival in small cell lung cancer? Lung Cancer. 2007;57[suppl 2]:S30 -S34.
5. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med. 1999;341:476-484.
6. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;327:1618- 1624.
7. Chute JP, Chen T, Feigal E, et al. Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. J Clin Oncol. 1999;17:1794-1801.
8. Hochstenbag MM, Twijnstra A, Wilmink JT, et al. Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol. 2000;48:243-248.
9. Grossi F, Scolaro T, Tixi L, et al. The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer. Crit Rev Oncol Hematol. 2001;37:61-67.
10. Seute T, Leffers P, ten Velde GP, et al. Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer. 2004;100: 801-806.
11. Hwang T, Close TP, Grego JM, et al. Predilection of brain metastasis in gray and white matter junction and vascular border zones. Cancer. 1996;77:1551-1555.
12. Graf AH, Buchberger W, Langmayr H, et al. Site preference of meta-static tumours of the brain. Virchows Arch A Pathol Anat Histopathol. 1988;412:493-498.
13. Nussbaum ES, Djalilian HR, Cho KH, et al. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer. 1996;78:1781-1788.
14. Seute T, Leffers P, ten Velde GP, et al. Leptomeningeal metastases from small cell lung carcinoma. Cancer. 2005;104:1700-1705.
15. van Oosterhout AG, van de Pol M, ten Velde GP, et al. Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study. Cancer. 1996;77:1434-1441.
16. Cavaliere R, Schiff D. Chemotherapy and cerebral metastases: misper-ception or reality? Neurosurg Focus. 2007;22:E6.
17. Zimm S, Wampler GL, Stablein D, et al. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer. 1981;48:384-394.
18. Videtic GM, Adelstein DJ, Mekhail TM, et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases. Int J Radiat Oncol Biol Phys. 2007;67: 240-243.
19. Schwer AL, Gaspar LE. Update in the treatment of brain metastases from lung cancer. Clin Lung Cancer. 2006;8:180-186.
20. Gaspar LE, Scott C, Murray K, et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000;47:1001-1006.
21. Soffietti R, Costanza A, Laguzzi E, et al. Radiotherapy and chemotherapy of brain metastases. J Neurooncol. 2005;75:31-42.
22. Quan AL, Videtic GM, Suh JH. Brain metastases in small cell lung cancer. Oncology (Williston Park). 2004;18:961-972; discussion 74, 79-80, 87.
23. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37: 745-751.
24. Postmus PE, Smit EF, Haaxma-Reiche H, et al. Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol. 1995;13:660-665.
25. Antonadou D, Paraskevaidis M, Sarris G, et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol. 2002;20:3644-3650.
26. Khuntia D, Brown P, Li J, et al. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol. 2006;24:1295-1304.
27. Peacock KH, Lesser GJ. Current therapeutic approaches in patients with brain metastases. Curr Treat Options Oncol. 2006;7:479-489.
28. Postmus PE, Haaxma-Reiche H, Gregor A, et al. Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study. Radiother Oncol. 1998;46:29-32.
29. Meyers CA, Smith JA, Bezjak A, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004;22:157-165.
30. Suh JH, Stea B, Nabid A, et al. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. J Clin Oncol. 2006;24:106-114.
31. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295:2483-2491.
32. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004;363:1665-1672.
33. Sneed PK, Suh JH, Goetsch SJ, et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys. 2002;53:519-526.
34. Serizawa T, Ono J, Iichi T, et al. Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma. J Neurosurg. 2002;97:484-488.
35. Sheehan J, Kondziolka D, Flickinger J, et al. Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg. 2005;102[suppl]:247-254.
36. Dagnew E, Kanski J, McDermott MW, et al. Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience. Neurosurg Focus. 2007;22:E3.
37. Mintz A, Perry J, Spithoff K, et al. Management of single brain metastasis: a practice guideline. Curr Oncol. 2007;14:131-143.
38. Abratt RP, de Groot M, Willcox PA. Resection of a solitary brain metastasis in a patient with small cell lung cancer-long-term survival. Eur J Cancer. 1995;31A:419.
39. Imai R, Hayakawa K, Sakurai H, et al. Small cell lung cancer with a brain metastasis controlled for 5 years: a case report. Jpn J Clin Oncol. 2001;31:116-118.
40. Ebert BL, Niemierko E, Shaffer K, et al. Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer. Oncologist. 2003;8:69-75.
41. Seute T, Leffers P, Wilmink JT, et al. Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy. J Clin Oncol. 2006;24:2079-2083.
42. Postmus PE, Smit EF. Chemotherapy for brain metastases of lung cancer: a review. Ann Oncol. 1999;10:753-759.
43. Postmus PE, Haaxma-Reiche H, Smit EF, et al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy - a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol. 2000;18:3400-3408.
44. Newton HB, Slivka MA, Volpi C, et al. Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors. J Neurooncol. 2003;61:35-44.
45. Fortin D, Gendron C, Boudrias M, et al. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis. Cancer. 2007;109:751-760.
46. Korfel A, Oehm C, von Pawel J, et al. Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation. A multicentre phase II study. Eur J Cancer. 2002;38: 1724-1729.
47. von Pawel J. The role of topotecan in treating small cell lung cancer: second-line treatment. Lung Cancer. 2003;41[suppl 4]:S3-S8.
48. Arriagada R, Le Chevalier T, Riviere A, et al. Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients. Ann Oncol. 2002;13:748-754.
49. Meert AP, Paesmans M, Berghmans T, et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer. 2001;1:5.
50. Felip E. Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2007;18:ii32-ii33.
51. NCCN Practice Guidelines in Oncology: Small Cell Lung Cancer 2008. Available at: http://www.nccn.org/professionals/physician-gls/PDF/ sclc.pdf. Accessed January 28, 2008.
52. Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med. 2007;357:664-672.
53. Slotman B, Postmus P, Senan S. Author's Reply to Letters. N Engl J Med. 2007;357:1977-1978.
54. Ettinger DS, Finkelstein DM, Abeloff MD, et al. A randomized com- parison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group. J Clin Oncol. 1990;8:230-240.
55. Schiller JH, Adak S, Cella D, et al. Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593-a phase III trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2001;19:2114-2122.
56. Arnold AM, Seymour L, Smylie M, et al. Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR. 20. J Clin Oncol. 2007;25:4278-4284.
57. Withers HR, Suwinski R. Radiation dose response for subclinical metastases. Semin Radiat Oncol. 1998;8:224-228.
58. RTOG Protocol No. 0212: A phase II/III randomized trial of two doses (phase III-standard vs. high) and two high dose schedules (phase II - once vs twice daily) for delivering prophylactic cranial irradiation for patients with limited disease small cell lung cancer (companion study to the International Cranial Irradiation Trial, PCI 01-EULINT1). Radiation Therapy Oncology Group, 2008. Available at: http://www. rtog.org/members/protocols/0212/0212.pdf. Accessed February 12, 2008.
59. DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989;39:789-796.
60. Laack NN, Brown PD. Cognitive sequelae of brain radiation in adults. Semin Oncol. 2004;31:702-713.
61. Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys. 1995;33:179-182.
62. Arriagada R, Le Chevalier T, Borie F, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst. 1995;87:183-190.
63. van Oosterhout AG, Boon PJ, Houx PJ, et al. Follow-up of cognitive functioning in patients with small cell lung cancer. Int J Radiat Oncol Biol Phys. 1995;31:911-914.
64. Gregor A, Cull A, Stephens RJ, et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer. 1997;33:1752-1758.
65. Grosshans DR, Meyers CA, Allen PK, et al. Neurocognitive function in patients with small cell lung cancer: effect of prophylactic cranial irradiation. Cancer. 2008;112:589-595.
66. Vardy J, Wefel JS, Ahles T, et al. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol. 2008;19:623-629.